2EH-18385-64143
2 vaccinations
4 coded responses
19 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 190 / PA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-24
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2020-12-30
Survey response — day 7, dose 1MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-20
- 2021-01-27
- 2021-02-03
-
2021-02-10
Survey response — day 28, dose 2MedDRA: Hypersensitivity, Sneezing — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Sneezing and allergieaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
- 2021-04-14
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-13 | Unsuccessful |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Nasal congestion
Release 4 — day 28, dose 2
Symptoms: Sneezing and allergiea
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 10 — 12 months, dose 2
Symptoms: Gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release